Соединенные Штаты - английский - NLM (National Library of Medicine)

zhejiang enchant cosmetic co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - disinfection sterilization no rinseing range of use: antibacterial and daily hand cleaning. direction for use: 1. squeeze out a small amount of formula properly and knead it with both hands. 2. lasting for 1-3 minutes.

Соединенные Штаты - английский - NLM (National Library of Medicine)

zhejiang enchant cosmetic co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - disinfection sterilization no rinseing range of use: antibacterial and daily hand cleaning. direction for use: 1. squeeze out a small amount of formula properly and knead it with both hands. 2. lasting for 1-3 minutes.

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - mesalazine 500mg;   - enteric coated tablet - 500 mg - active: mesalazine 500mg   excipient: colloidal silicon dioxide crospovidone hypromellose povidone k90   methacrylic acid - methyl metacrylate copolymer (1:2) iron oxide yellow macrogol 6000   magnesium stearate   microcrystalline cellulose povidone purified talc titanium dioxide triethyl citrate - the treatment of crohn's disease localised to the colon.

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - mercaptopurine monohydrate 50mg; mercaptopurine monohydrate 50mg - tablet - 50 mg - active: mercaptopurine monohydrate 50mg excipient: lactose monohydrate magnesium stearate maize starch stearic acid active: mercaptopurine monohydrate 50mg excipient: lactose monohydrate magnesium stearate maize starch stearic acid - puri-nethol is indicated for the treatment of acute leukaemia. it may be utilised in remission induction and is particularly indicated for maintenance therapy in: · acute lymphoblastic leukaemia; · acute myelogenous leukaemia.

Соединенные Штаты - английский - NLM (National Library of Medicine)

zhejiang huahai pharmaceutical co., ltd. - ropinirole hydrochloride (unii: d7zd41rzi9) (ropinirole - unii:030pyr8953) - ropinirole hydrochloride 0.25 mg - ropinirole hydrochloride tablets are indicated for the treatment of the signs and symptoms of idiopathic parkinson’s disease. the effectiveness of ropinirole hydrochloride was demonstrated in randomized, controlled trials in patients with early parkinson’s disease who were not receiving concomitant l-dopa therapy as well as in patients with advanced disease on concomitant l-dopa (see clinical pharmacology: clinical trials). ropinirole hydrochloride tablets are indicated for the treatment of moderate-to-severe primary restless legs syndrome (rls). key diagnostic criteria for rls are: an urge to move the legs usually accompanied or caused by uncomfortable and unpleasant leg sensations; symptoms begin or worsen during periods of rest or inactivity such as lying or sitting; symptoms are partially or totally relieved by movement such as walking or stretching at least as long as the activity continues; and symptoms are worse or occur only in the evening or night. difficulty falling asleep may frequently be associ

Соединенные Штаты - английский - NLM (National Library of Medicine)

zhejiang jingwei pharmaceutical co., ltd. - bacitracin (unii: 58h6rwo52i) (bacitracin - unii:58h6rwo52i), neomycin (unii: i16qd7x297) (neomycin - unii:i16qd7x297), polymyxin b (unii: j2vz07j96k) (polymyxin b - unii:j2vz07j96k) - bacitracin .41 g in 100 g - purpose first aid antibiotic uses first aid to help prevent infection in minor: -cuts -scrapes -burns stop use and ask a doctor if -symptoms last for more than 7 days, the condition persists or gets worse -symptoms clear up and then occur again within a few days -a rahs or other allergic reaction occurs

Соединенные Штаты - английский - NLM (National Library of Medicine)

zhejiang jingwei pharmaceutical co., ltd. - bacitracin (unii: 58h6rwo52i) (bacitracin - unii:58h6rwo52i), neomycin (unii: i16qd7x297) (neomycin - unii:i16qd7x297), polymyxin b (unii: j2vz07j96k) (polymyxin b - unii:j2vz07j96k) - bacitracin .41 g in 100 g - purpose first aid antibiotic uses first aid to help prevent infection in minor: -cuts -scrapes -burns stop use and ask a doctor if -symptoms last for more than 7 days, the condition persists or gets worse -symptoms clear up and then occur again within a few days -a rash or other allergic reaction occurs

Соединенные Штаты - английский - NLM (National Library of Medicine)

zhejiang fonow medicine co., ltd. - bacitracin (unii: 58h6rwo52i) (bacitracin - unii:58h6rwo52i), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) - bacitracin 500 [iu] in 1 g - first aid antibiotic first aid antibiotic first aid antibiotic anesthetic uses fist aid to help prevent infection and provide temporary pain relief in minor cuts scrapes burns if allergic to any of the ingredients in or near the eyes over large areas of the body stop use and ask a doctor if condition lasts or gets worse symptoms last for more than 7 days or clear up and come back within a few days a rash or other allergic reaction occurs

Соединенные Штаты - английский - NLM (National Library of Medicine)

trupharma, llc - paroxetine hydrochloride anhydrous (unii: 3i3t11ud2s) (paroxetine - unii:41vrh5220h) - paroxetine 10 mg - major depressive disorder: paroxetine tablets are indicated for the treatment of major depressive disorder. the efficacy of paroxetine tablets in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology: clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine tablets in hospitalized depressed patients have not been adequately studied.

Соединенные Штаты - английский - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - paroxetine hydrochloride anhydrous (unii: 3i3t11ud2s) (paroxetine - unii:41vrh5220h) - paroxetine 20 mg - major depressive disorder: paroxetine tablets are indicated for the treatment of major depressive disorder. the efficacy of paroxetine tablets in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology: clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine tablets in hospitalized depressed patients have not been adequately studied.